文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Echocardiographic Calcium Score of Aortic Valve Correlates with Coronary Artery Calcium Score in Heterozygous Familial Hypercholesterolemia.

作者信息

Cefalù Angelo Baldassare, Nardi Emilio, Giammanco Antonina, Gagliardo Carola Maria, Barbagallo Carlo Maria, La Grutta Ludovico, Toia Patrizia, Brucato Federica, Scrimali Chiara, Fasciana Teresa Maria Grazia, Spina Rossella, Lanza Marina, Vitale Francesco, Noto Davide, Averna Maurizio

机构信息

Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro" (PROMISE), University of Palermo, Via del Vespro 129, 90127 Palermo, Italy.

Section of Radiology, Department of Biomedicine, Neurosciences and Advanced Diagnostics (BiND), University Hospital "Paolo Giaccone", 90127 Palermo, Italy.

出版信息

Life (Basel). 2025 Mar 20;15(3):506. doi: 10.3390/life15030506.


DOI:10.3390/life15030506
PMID:40141850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11943964/
Abstract

BACKGROUND: Patients with heterozygous familial hypercholesterolemia (HeFH) are at a high risk of atherosclerotic cardiovascular disease. The coronary artery calcification (CAC) score by the Ct-scan Agatston calcium score (ACS) > 100 classifies FH at a higher risk. The echocardiographic calcium score (ECS) evaluates aortic valve calcifications and is considered a good predictor of the atherosclerotic burden and cardiovascular outcome. OBJECTIVE: To test the ECS as a predictor of ACS > 100 in a HeFH cohort. METHODS: A coronary calcium CT scan with the calculation of ACS and an at rest-transthoracic echocardiogram with ECS evaluation were performed in 81 HeFH patients. Patients were divided into two groups according to the ACS: high-risk ACS patients (High-ACS) with Agatston value > 100 and low risk ACS patients (Low-ACS) with Agatston value ≤ 100. Patients were stratified according to ECS = 0 or ECS > 0. RESULTS: High-ACS patients were older than Low-ACS patients; BMI, waist circumference, and blood systolic pressure were significantly higher ( < 0.001) in High-ACS patients. The ECS predicted an ACS > 100 with sensitivity = 0.84, specificity = 0.89, accuracy = 0.86, and precision = 0.76. CONCLUSIONS: The ECS could be a good surrogate of a coronary calcium CT scan for ACS evaluation in the specific subset of HeFH patients.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ae/11943964/45072362ce65/life-15-00506-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ae/11943964/d0b9480b0c9d/life-15-00506-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ae/11943964/45072362ce65/life-15-00506-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ae/11943964/d0b9480b0c9d/life-15-00506-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ae/11943964/45072362ce65/life-15-00506-g002.jpg

相似文献

[1]
Echocardiographic Calcium Score of Aortic Valve Correlates with Coronary Artery Calcium Score in Heterozygous Familial Hypercholesterolemia.

Life (Basel). 2025-3-20

[2]
The Added Value of Coronary Calcium Score in Predicting Cardiovascular Events in Familial Hypercholesterolemia.

JACC Cardiovasc Imaging. 2021-12

[3]
Increased Aortic Valve Calcification in Familial Hypercholesterolemia: Prevalence, Extent, and Associated Risk Factors.

J Am Coll Cardiol. 2015-12-22

[4]
Lower attenuation and higher kurtosis of coronary artery calcification associated with vulnerable plaque - an agatston score propensity-matched CT radiomics study.

BMC Cardiovasc Disord. 2023-3-27

[5]
Aortic valve and arterial calcification in patients with familial hypercholesterolemia.

Kardiol Pol. 2024

[6]
Early coronary calcifications are related to cholesterol burden in heterozygous familial hypercholesterolemia.

J Clin Lipidol. 2017

[7]
Coronary Artery Calcium Is Independently Associated with Arterial Stiffness and LDL Cholesterol Burden in Patients with Familial Hypercholesterolemia.

J Clin Med. 2025-2-13

[8]
Differences in the association of total versus local coronary artery calcium with acute coronary syndrome and culprit lesions in patients with acute chest pain: The coronary calcium paradox.

Atherosclerosis. 2018-4-17

[9]
Correlates of Coronary Artery Calcification Prevalence and Severity in Patients With Heterozygous Familial Hypercholesterolemia.

CJC Open. 2020-9-16

[10]
Evaluation of Clinical Applicability of Coronary Artery Calcium Assessment on Non-Gated Chest Computed Tomography, Compared With the Classic Agatston Score on Cardiac Computed Tomography.

Am J Cardiol. 2023-12-1

本文引用的文献

[1]
Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA).

Nutr Metab Cardiovasc Dis. 2024-8

[2]
Vascular Calcification: Molecular Networking, Pathological Implications and Translational Opportunities.

Biomolecules. 2024-2-25

[3]
Stratification in Heterozygous Familial Hypercholesterolemia: Imaging, Biomarkers, and Genetic Testing.

Curr Atheroscler Rep. 2023-12

[4]
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance.

Eur Heart J. 2023-7-1

[5]
Updates on the Use of Subclinical Atherosclerosis to Predict Risk of Cardiovascular Events in Heterozygous Familial Hypercholesterolemia.

Curr Atheroscler Rep. 2022-6

[6]
Diagnosis of familial hypercholesterolemia in a large cohort of Italian genotyped hypercholesterolemic patients.

Atherosclerosis. 2022-4

[7]
Aortic valve calcification predicts all-cause mortality independent of coronary calcification and severe stenosis.

Atherosclerosis. 2020-8

[8]
Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects.

J Am Coll Cardiol. 2020-5-26

[9]
Framingham General Cardiovascular Risk Score and Cognitive Impairment: The Power of Foresight.

J Am Coll Cardiol. 2020-5-26

[10]
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

Eur Heart J. 2020-1-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索